Breast and Gynecologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Recruiting
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer Bexarotene, Laboratory Biomarker Analysis, Questionnaire Administration NCT03323658 National Cancer Institute (NCI) Recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Pharmacokinetic Study, Exemestane, Laboratory Biomarker Analysis, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim NCT02636582 National Cancer Institute (NCI) Active, not recruiting
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Placebo, Metformin NCT02028221 University of Arizona Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Questionnaire Administration, Z-Endoxifen Hydrochloride NCT03317405 National Cancer Institute (NCI) Recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting
Preventive Human Papilomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting

Pages